Efficacy and safety of Tanreqing oral liquid in treatment of acute bronchitis: study protocol for a randomized controlled trial
This study is a prospective, multi-center, randomized, double-blinded, parallel-group, placebo-controlled trial. A total of 270 acute bronchitis adult patients with phlegm-heat obstructing lungs syndrome will be enrolled from outpatients and emergency departments at nine study centers across China. All included patients will be randomly allocated to receive Tanreqing oral liquid or placebo oral liquid, 20 mL three times daily for seven consecutive days. The primary outcome will be cough resolution rate. Secondary outcomes will include change of bronchitis symptoms scores from baseline to post-treatment, cough relief rate, ...
Source: Trials - May 7, 2022 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate the Safety and Efficacy of " AG1904 " in Acute Bronchitis
Condition: Acute Bronchitis Interventions: Drug: AGS (Experimental); Drug: AGU (Active Comparator) Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2022 Category: Research Source Type: clinical trials
